References
- World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report 1. 2020.
- John Hopkins University. COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins University (JHU); 2020 [accesed 2021 Apr 30]. https://coronavirus.jhu.edu/map.html .
- The World Bank. HIGHLIGHTS from CHAPTER 1 THE GLOBAL OUTLOOK. Glob. Econ. Prospect., Washington (DC): The World Bank; 2021.
- Corona Tracker. Corona Tracker; 2020 [accesed 2021 Mar 30]. https://www.coronatracker.com/country/kenya/ .
- IMF. Regional economic outlook for Sub-Saharan Africa, June 2020 Update. IMF; 2020 [accesed 2020 Sep 17]. https://www.imf.org/en/Publications/REO/SSA/Issues/2020/06/29/sreo0629 .
- The New York Times. Coronavirus Vaccine Tracker; 2020 [accessed 2021 Dec 30]. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html .
- Deroo SS, Pediatrics C, George T, Sciences H, Pudalov NJ, George T, Sciences H, Sciences H, Pudalov NJ, George T, et al. Planning for a COVID-19 vaccination program. JAMA. 2020;323:2458–59. https://doi.org/10.1001/jama.2020.8711 .
- Lusk JL, Hudson D. Willingness-to-pay estimates and their relevance to agribusiness decision making. Rev Agric Econ. 2004;26:152–69. doi:10.1111/j.1467-9353.2004.00168.x.
- Lee JS, Mogasale V, Lim JK, Carabali M, Sirivichayakul C, Anh DD, Lee K-S, Thiem VD, Limkittikul K, Tho LH, et al. A multi-country study of the household willingness-to-pay for dengue vaccines: household surveys in Vietnam, Thailand, and Colombia. PLoS Negl Trop Dis. 2015;9:1–15. doi:10.1371/journal.pntd.0003810.
- Ughasoro MD, Esangbedo DO, Tagbo BN, Mejeha IC. Acceptability and willingness-to-pay for a hypothetical ebola virus vaccine in Nigeria. PLoS Negl Trop Dis. 2015;9:1–15. doi:10.1371/journal.pntd.0003838.
- Cropper ML, Haile M, Lampietti J, Poulos C, Whittington D. The demand for a malaria vaccine: evidence from Ethiopia. J Dev Econ. 2004;75:303–18. doi:10.1016/j.jdeveco.2003.02.006.
- Hadisoemarto PF, Castro MC. Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia. PLoS Negl Trop Dis. 2013;7:e2427. doi:10.1371/journal.pntd.0002427.
- McNeil SA, Shinde V, Andrew M, Hatchette TF, Leblanc J, Ambrose A, Boivin G, Bowie WR, Diaz-Mitoma F, ElSherif M, et al. Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of. Euro Surveill. 2014;19:1–6.
- Hou Z, Chang J, Yue D, Fang H, Meng Q, Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine. 2014;32:4471–77. doi:10.1016/j.vaccine.2014.06.047.
- Berghea F, Berghea CE, Abobului M, Vlad VM Willingness to Pay for a for a Potential Vaccine Against SARS-CoV-2/COVID-19 Among Adult Persons; 2020.
- Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Vo TQ, et al. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum Vaccin Immunother. 2020;16:3074–80. doi:10.1080/21645515.2020.1819741.
- Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16(9):1–11.
- Wang J, Lyu Y, Zhang H, Jing R, Lai X, Feng H, Knoll MD, Fang H. Willingness to pay and financing preferences for COVID-19 vaccination in China. Vaccine. 2021;39:1968–76. doi:10.1016/j.vaccine.2021.02.060.
- Zhang Y, Luo X, Ma ZF. Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China. Hum Vaccin Immunother. 2021;17(6):1–6.
- García LY, Cerda AA. Contingent assessment of the COVID-19 vaccine. Vaccine. 2020;38:5424–29. doi:10.1016/j.vaccine.2020.06.068.
- Sarasty O, Carpio CE, Hudson D, Guerrero-Ochoa PA, Borja I. The demand for a COVID-19 vaccine in Ecuador. Vaccine. 2020;38:8090–98. doi:10.1016/j.vaccine.2020.11.013.
- Cerda AA, García LY. Willingness to pay for a COVID-19 vaccine. Appl Health Econ Health Policy. 2021;19:1–9.
- Catma S, Reindl D. Parents’ willingness to pay for a COVID-19 vaccine for themselves and their children in the United States. Hum Vaccin Immunother. 2021;1–7. doi:10.1080/21645515.2021.1919453.
- Carpio C, Hudson D, Sarasty O, Macharia A, Shibia M Public knowledge, perceptions, responses and effects related to the COVID-19 health emergency: The Case of Kenya; 2020.
- Ipsos Public Affairs. SPEC barometer, 1st QTR 2018 second media release. Ipsos Public Aff; 2018 [accesed 2020 Sep 14]. https://www.ipsos.com/sites/default/files/ct/news/documents/2019-08/ipsoske_spec_1st_release_presentation_pa_v1.pdf .
- Kenya National Bureau of Statistics. Economic survey 2019. Kenya Natl Bur Stat; 2019 [accesed 2020 Oct 13]. https://www.knbs.or.ke/?wpdmpro=economic-survey-2019 .
- Kenya National Bureau of Statistics. Kenya demographic and health survey 2014. Kenya Natl Bur Stat; 2015 [accesed 2020 Sep 14]. https://dhsprogram.com/pubs/pdf/FR308/FR308.pdf .
- The World Bank. Kenya overview. World Bank; 2020 [accesed 2020 Sep 17]. https://data.worldbank.org/country/kenya .
- Mboya E Kenya overtakes Angola as third-largest economy in Sub-Sahara Africa. Bus Dly; 2020 [accesed 2020 Sep 17]. https://theconversation.com/covid-19-exposes-weaknesses-in-kenyas-healthcare-system-and-what-can-be-done-143356 .
- The Conversation. COVID-19 exposes weaknesses in Kenya’s healthcare system. And what can be done. Conversat; 2020 [accesed 2020 Sep 17]. https://theconversation.com/covid-19-exposes-weaknesses-in-kenyas-healthcare-system-and-what-can-be-done-143356 .
- Halloran ME, Haber M, Longini IM Jr, Struchiner CJ. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol. 1991;133:323–31. doi:10.1093/oxfordjournals.aje.a115884.
- Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63:1055–68.
- Centers of Disease Control and Prevention. CDC seasonal flu vaccine effectiveness studies; 2020 [accesed 2020 Aug 23]. https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm .
- O’Donnell T Oxford scientist says if coronavirus vaccine is effective it will likely be seasonal; 2020 [accesed 2020 Aug 23]. https://news.yahoo.com/oxford-scientist-says-coronavirus-vaccine-172827584.html .
- Kekatos M Coronavirus mutates slower than the flu say experts - which will give scientists longer to develop an effective vaccine; 2020 [accesed 2020 Aug 23]. https://www.dailymail.co.uk/news/article-8208379/Coronavirus-mutating-slowly-giving-scientists-time-develop-vaccine.html .
- AfricaPay. Minimum wages in Kenya with effect from 01-05-2018; 2018 [accessed 2021 Mar 31]. https://africapay.org/kenya/salary/minimum-wages/archive-before-2019/minimum-wages-in-kenya-with-effect-from-01-05-2018
- Cameron TA, James MD. Efficient estimation methods for” closed-ended” contingent valuation surveys. Rev Econ Stat. 1987;69:269–76. doi:10.2307/1927234.
- Haab TC, McConnell KE. Valuing environmental and natural resources: the econometrics of non-market valuation. Northampton (MA): Edward Elgar Publishing; 2002.
- Carpio CE, Ramirez OA, Boonsaeng T. Potential for tradable water allocation and rights in Jordan. Land Econ. 2011;87:595–609. doi:10.3368/le.87.4.595.
- Turnbull BW. The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Stat Soc Ser B. 1976;38:290–95. doi:10.1111/j.2517-6161.1976.tb01597.x.
- Day B. Distribution-free estimation with interval-censored contingent valuation data: troubles with Turnbull? Environ Resour Econ. 2007;37:777–95. doi:10.1007/s10640-006-9061-8.
- Haab TC, McConnell KE. Referendum models and negative willingness to pay: alternative solutions. J Environ Econ Manage. 1997;32:251–70. doi:10.1006/jeem.1996.0968.
- Cameron T, New A. Paradigm for valuing non-market goods using referendum data: maximum likelihood estimation by censored logistic regression. J Environ Econ Manage. 1988;15:355–79. doi:10.1016/0095-0696(88)90008-3.
- López-Feldman A. Munich Personal RePEc Archive Introduction to contingent valuation using Stata Introduction to Contingent Valuation using Stata *; 2012.
- Cameron A, Trivedi P. Microeconometrics: methods and application. New York: Cambridge University Press; 2009.
- Raqab MZ, Al-Awadhi SA, Kundu D. Discriminating among weibull, log-normal, and log-logistic distributions. Commun Stat - Simul Comput. 2018;47:1397–419. doi:10.1080/03610918.2017.1315729.
- Detoc M, Bruel S, Frappe P, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. MedRxiv 2020. 2020 04 23;20076513. doi:10.1101/2020.04.23.20076513.
- Thunstrom L, Ashworth M, Finnoff D, Newbold S Hesitancy Towards a COVID-19 Vaccine and Prospects for Herd Immunity. Available SSRN 3593098 2020.
- Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in southeast Asia: a cross-sectional study in Indonesia. Front Public Heal. 2020;8.
- Mudatsir M, Anwar S, Fajar JK, Yufika A, Ferdian MN, Salwiyadi S, Imanda AS, Azhars R, Ilham D, Timur AU, et al. Willingness-to-pay for a hypothetical Ebola vaccine in Indonesia: a cross-sectional study in Aceh. F1000Research. 2019;8:1441. doi:10.12688/f1000research.20144.2.
- Brown DS, Johnson FR, Poulos C, Messonnier ML. Mothers’ preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine. 2010;28:1702–08. doi:10.1016/j.vaccine.2009.12.024.
- Arbiol J, Yabe M, Nomura H, Borja M, Gloriani N, Yoshida SI. Using discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccine. Hum Vaccines Immunother. 2015;11:1046–56. doi:10.1080/21645515.2015.1010901.
- Cameron MP, Newman PA, Roungprakhon S, Scarpa R. The marginal willingness-to-pay for attributes of a hypothetical HIV vaccine. Vaccine. 2013;31:3712–17. doi:10.1016/j.vaccine.2013.05.089.
- CDC. Coronavirus disease older adults. CDC; 2020 [accesed 2020 Sep 13]. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults.html .
- Bishai D, Brice R, Girod I, Saleh A, Ehreth J. Conjoint analysis of French and German parents’ willingness to pay for meningococcal vaccine. Pharmacoeconomics. 2007;25:143–54. doi:10.2165/00019053-200725020-00006.
- WHO. The current COVID-19 situation: kenya; 2020 [accesed 2020 Aug 27]. https://www.who.int/countries/ken/ .
- Loftus P Covid-19 vaccine makers signal prices 2020 [accesed 2020 Aug 23]. https://www.wsj.com/articles/covid-19-vaccine-makers-signal-prices-11596648639 .